By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


T2 Biosystems 

101 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-457-1200 Fax: 781-357-3080



Company News
T2 Biosystems (TTOO) Announces Presentations Featuring T2Candida And T2Dx At IDWeek 2014 10/8/2014 7:07:16 AM
T2 Biosystems (TTOO) Receives FDA Authorization To Market T2Candida And T2Dx For The Detection Of Sepsis-Causing Pathogens 9/23/2014 7:43:19 AM
T2 Biosystems (TTOO) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 8:02:37 AM
T2 Biosystems (TTOO) Announces Closing Of Initial Public Offering 8/12/2014 3:07:06 PM
Massachusett's T2 Biosystems (TTOO) Goes Public, Raises $57 Million 8/7/2014 7:39:22 AM
MRI Diagnostics Maker T2 Biosystems Boosts IPO Cap To $78.2 Million 7/31/2014 7:25:26 AM
Diagnostics Developer T2 Biosystems Files For A $69 Million IPO 7/3/2014 7:39:07 AM
T2 Biosystems Release: Clinical Chemistry Study Reports On Use Of T2MR To Evaluate Hemostasis In Whole Blood 6/23/2014 11:08:27 AM
T2 Biosystems Submits 510(K) Application To The FDA For Review Of T2Dx And T2Candida 6/3/2014 9:52:28 AM
T2 Biosystems Presents New Data At The Thrombosis And Hemostasis Summit Of North America Demonstrating Ability Of T2MR Platform Technology To Measure Platelet Activity And Additional Hemostasis Parameters 4/10/2014 7:31:28 AM